Mechanism of the susceptibility of remodeled pulmonary vessels to drug-induced cell killing. - Test2 - elhamkhani - TriplyDB

Mechanism of the susceptibility of remodeled pulmonary vessels to drug-induced cell killing.

Mechanism of the susceptibility of remodeled pulmonary vessels to drug-induced cell killing.

http://www.wikidata.org/entity/Q37648641

about

Oxidative profiling of the failing right heart in rats with pulmonary hypertension The cancer theory of pulmonary arterial hypertension.Carfilzomib reverses pulmonary arterial hypertension.Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.A Hypothesis Concerning the Biphasic Dose-response of Tumors to Angiostatin and Endostatin.Pulmonary arterial hypertension in primary amyloidosis.Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs Docetaxel Reverses Pulmonary Vascular Remodeling by Decreasing Autophagy and Resolves Right Ventricular Fibrosis.Redox Biology of Right-Sided Heart Failure

P2860

Q33637652-77EC7E7A-A042-4949-9AB4-81F103A31795 Q33788493-F6394C81-53B4-4496-8BC6-CD4A00D2AABB Q36812649-F5D83BA9-E44E-4DC9-A9FB-CA80AFF20DDA Q41412846-E72A8BE5-2917-4A47-9BC5-F32C51B8F3CF Q41789743-A288FF5C-742C-425C-B96D-F9487D89ABA4 Q42148286-B715D4D1-8D51-437C-BB1E-9827DAD0618F Q42361271-69ECFCC1-0E8E-4CA6-B8AB-65BE9A46ABBD Q46547122-6FC97DAF-A9E8-47A3-863D-4EED0005E155 Q58795160-56933B32-F786-4FB4-92F5-FEA6C62C20F0

P2860

Mechanism of the susceptibility of remodeled pulmonary vessels to drug-induced cell killing.

http://www.wikidata.org/entity/Q37648641

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Mechanism of the susceptibilit ...... to drug-induced cell killing.

@en

Mechanism of the susceptibilit ...... to drug-induced cell killing.

@nl

type

label

Mechanism of the susceptibilit ...... to drug-induced cell killing.

@en

Mechanism of the susceptibilit ...... to drug-induced cell killing.

@nl

prefLabel

Mechanism of the susceptibilit ...... to drug-induced cell killing.

@en

Mechanism of the susceptibilit ...... to drug-induced cell killing.

@nl

P1433

Q37648641-A7FF8278-E16A-41C9-BE1A-5BF9E5839F87

P1476

Q37648641-599BA7BD-C6F5-413C-AA1B-3E6CB235FF17

P2093

Q37648641-0609C977-1B26-4552-B876-76876081A7CC

Q37648641-1962CA58-3C1E-4751-AB8E-F70A3A4BE0E7

Q37648641-5980D01D-46BF-4302-A80C-AA0037B04C1E

Q37648641-7D2D4F41-1F82-411F-8DA2-78DAF3316A98

Q37648641-95D23B62-C863-405A-B093-A05AA494BF6F

Q37648641-A0692BEE-44AD-4687-9F15-6BB379179062

Q37648641-BF93CAB2-FA83-4025-A8BB-89BCBFAE9EA6

P2860

Q37648641-1A1CB77C-9D90-49CF-9815-F8674323A00D

Q37648641-27017F09-4299-4FC7-B5C9-5950DA3A0FA9

Q37648641-3E2AA627-9F71-4F79-96E4-BBF0652CE682

Q37648641-40B5A811-5943-4F8B-9323-8EB5AF760AE2

Q37648641-46655A23-5D60-4B1E-9F11-C2814649D7CF

Q37648641-568A27A8-8623-492C-B9D2-1775A79C08D4

Q37648641-5B8B74BD-0709-4F56-BFAB-6A4F0DE694B7

Q37648641-69A07100-FADD-4520-B856-B2B28E0F4139

Q37648641-6E75E5CD-FDD1-40ED-BDA3-6E1DA4840AB4

Q37648641-760DFE04-D561-42C2-B23B-A8ECD6FDFE60

P304

Q37648641-E35C6CE7-B525-4CFD-B14E-4279EBDC184E

P31

Q37648641-4E9C3596-AFF7-4D4B-9AA1-D790BD744FF1

P356

Q37648641-AE3F6432-D30A-4F88-842D-07683D449558

P433

Q37648641-AEFB1047-94EE-4987-A6D1-C3295361A1AB

P478

Q37648641-685C5106-E658-4838-AA43-E55A473B216B

P577

Q37648641-224907B4-CB6D-418B-89AB-5B6E90E8DE94

P5875

Q37648641-17A5CBA2-3478-41F6-AC75-14422D757A70

P698

Q37648641-8BFC96CE-4E5D-4BA8-BD58-D93A17F10613

P932

Q37648641-3A1B3EA5-5F0C-40D9-AE24-533A46FD1C85

P356

JAHA.113.000520

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Mechanism of the susceptibilit ...... to drug-induced cell killing.

@en

P2093

Chi-Ming Wong

http://www.w3.org/2001/XMLSchema#string

Geetanjali Bansal

http://www.w3.org/2001/XMLSchema#string

Lingling Liu

http://www.w3.org/2001/XMLSchema#string

Lobsang Trasar

http://www.w3.org/2001/XMLSchema#string

Ludmila Pavlickova

http://www.w3.org/2001/XMLSchema#string

Yasmine F Ibrahim

http://www.w3.org/2001/XMLSchema#string

Yuichiro J Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

Autophagy in the Pathogenesis of Disease

Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene

The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals

Regulation of Bcl-xL expression in lung vascular smooth muscle

How to interpret LC3 immunoblotting

Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.

Clinical study of daunomycin and prednisone for induction of remission in children with advanced leukemia.

Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry.

P304

e000520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.113.000520

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260393339

http://www.w3.org/2001/XMLSchema#string

P698

24572252

http://www.w3.org/2001/XMLSchema#string

P932

3959719

http://www.w3.org/2001/XMLSchema#string